US FDA approved of XHANCE as the first and only medication for adults with chronic rhinosinusitis without nasal polyps. It is a fluticasone propionate nasal spray which uses the Exhalation Delivery System to enable topical steroid to the inflamed areas and is proven effective.
Resource Categories:
- Allergic Conjunctivitis
- Allergic Rhinitis
- Allergies
- Allergy Desensitization (Allergy shots)
- Alpha-One Anti-Trypsin Deficiency
- Anaphylaxis
- Asthma
- Atopic Dermatitis / Eczema
- Autoimmunity
- Autoinflammation
- Celiac Disease
- Chronic Obstructive Lung Disease (COPD) / Emphysema
- Chronic Sinusitis
- Clinical Research
- Clinical Resources
- Contact Dermatitis
- Drug Updates
- Dust Mite Allergies
- Eosinophilic Esophagitis
- Food Allergies / Intolerance
- For Physicians
- Gene test
- Hereditary Angioedema
- Hives (Urticaria)
- Immune System
- immune system disorders
- Immunodeficiency
- Immunodeficiency Hypogammaglobulinemia
- immunology
- Infusion center
- mast cells
- Mast Cells Activation Syndrome (MCAS)
- Medication Allergies
- Mold Allergies
- News
- PANS/PANDAS
- patient advocacy
- Patient Opportunity
- Patient Resources
- Pet Allergies
- Pollen Allergies
- Rare Diseases
- Recurrent Infection
- Respiratory Diseases
- Severe Asthma
- Sinusitis
- Skin Conditions (Psoriasis)
- Sports Related Asthma
- springfield community
- Type 2 Inflammation
- Uncategorized